MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 11, 2007; DOI: 10.1124/mol.107.039040


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.039040v1
72/6/1466    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sareen, D.
Right arrow Articles by Polans, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sareen, D.
Right arrow Articles by Polans, A. S.


Received for publication June 14, 2007.
Revised August 28, 2007.
Accepted for publication September 10, 2007.

Mitochondria, Calcium, and Calpain are Key Mediators of Resveratrol-Induced Apoptosis in Breast Cancer

Dhruv Sareen 1, Soesiawati R. Darjatmoko 1, Daniel M. Albert 1, Arthur S. Polans 1*

1 University of Wisconsin - Madison

* Address correspondence to: E-mail: aspolans{at}wisc.edu

Abstract

Resveratrol (RES), a natural plant polyphenol, has gained interest as a non-toxic chemopreventive agent capable of inducing tumor cell death in a variety of cancer types. However, the early molecular mechanisms of RES-induced apoptosis are not well defined. Using the human breast cancer cell lines MDA-MB-231 and MCF-7, we demonstrate that RES is anti-proliferative and induces apoptosis in a concentration- and time-dependent manner. Preceding apoptosis, RES instigates a rapid dissipation of mitochondrial membrane potential ({Delta}{Psi}m) by directly targeting mitochondria. This is followed by release of cytochrome c and Smac/DIABLO into the cytoplasm and substantial increase in the activities of caspases-9 and -3 in MDA-MB-231 cells. Additionally, live cell microscopy demonstrates that RES causes an early biphasic increase in the concentration of free intracellular calcium ([Ca2+]i), likely resulting from depletion of the endoplasmic reticulum (ER) stores in breast cancer cells. In caspase-3 deficient MCF-7 cells apoptosis is mediated by the Ca2+- activated protease, calpain, leading to the degradation of plasma membrane Ca2+-ATPase isoform 1 (PMCA1) and fodrin; the degradation is attenuated by buffering [Ca2+]i and blocked by calpain inhibitors. Mitochondrial permeability transition pore antagonists also blocked calpain activation. In vivo mouse xenograft studies demonstrate that RES treatment inhibits breast cancer growth with no systemic toxicities. Collectively, these results suggest a critical role for mitochondria not only in the intrinsic apoptotic pathway but also in the Ca2+ and calpain-dependent cell death initiated by RES. Thus, RES may prove useful as a non-toxic alternative for breast cancer treatment.


Key words: Structure-activity relationships and modeling, Ca imaging, Fluorescence techniques, Structure/function/mechanism, Apoptosis, Mitochondrial toxins, Mechanisms of cell killing/apoptosis


This article has been cited by other articles:


Home page
IOVSHome page
P. R. van Ginkel, S. R. Darjatmoko, D. Sareen, L. Subramanian, S. Bhattacharya, M. J. Lindstrom, D. M. Albert, and A. S. Polans
Resveratrol Inhibits Uveal Melanoma Tumor Growth via Early Mitochondrial Dysfunction
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1299 - 1306.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics